Lexaria Bioscience Corp. LEXX
Set alert
4.00 USD +0.36 +9.89%
As of Nov 3, 2:53 PM ET
3.79 Day range 4.10
2.43 52-week range 21.60
- YTD
- -56.80%
- 1 year
- -74.36%
- Open
- 3.79
- Prev close
- 3.64
- Mkt cap
- 8.43M
- Vol
- 19.65K
- Avg vol
- 74.60K
- EPS
- -5.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.79
- High
- 4.10
- Forward P/E
- -5.64
- Beta
- 1.06
- Short ratio
- 2.34
- Inst. own
- 6.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 10, 2025
- 50-d avg
- 2.38
- 200-d avg
- 2.99
- 1y target
- 10.00
Held by funds
1 US ETFs and mutual funds hold LEXX · largest positions
| Fund | Value held | Weight in fund |
|---|---|---|
| VXF | 0.00% |
Ownership
Held by insiders 7.03%
Held by institutions 6.08%
Float held by institutions 6.54%
Institutions 26
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Invenomic Capital Management, LP | 0.59% | 475,773 | 1.05M | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.19% | 150,391 | 330.86K | Sep 29, 2024 |
| Vanguard Group Inc | 0.14% | 109,022 | 239.85K | Sep 29, 2024 |
| GenTrust, LLC | 0.07% | 60,000 | 132.00K | Sep 29, 2024 |
| Raymond James Financial Services Advisors, Inc. | 0.06% | 44,900 | 98.78K | Sep 29, 2024 |
| State Street Corporation | 0.05% | 39,301 | 86.46K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Northern Lights Fd Tr II-Invenomic Fd | 0.33% | 263,417 | 579.52K | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 0.12% | 98,818 | 217.40K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.10% | 80,525 | 177.16K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.03% | 26,368 | 58.01K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.02% | 19,734 | 43.41K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 8,916 | 19.61K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CARLE VANESSA | Officer | Sale | Jul 30, 2024 | 0 |
| CHRISTOPHER RICHARD C | Chief Executive Officer | Purchase | Dec 2, 2024 | 50,000 |
| TURKEL CATHERINE C | Director | Purchase | Aug 11, 2024 | 3,100 |